16S V3-V4 rRNA gene sequencing of clinician-collected bacterial vaginosis diagnosed samples

Bacterial vaginosis (BV) poses a significant health burden for women during reproductive years and onward. Current BV diagnostics rely on either physical and microscopic evaluations by technicians or panels of select microbes. Here, we sequenced the microbiome profiles of samples previously diagnosed by the Labcorp NuSwab test to better understand disruptions to the vaginal microbiome during BV. We show that microbial sequencing can reproduce targeted panel diagnostic results, while also broadly characterizing healthy and BV-associated microbial and metabolic biomarkers. This work highlights a robust, agnostic BV classification scheme with potential for future development of sequencing-based BV diagnostic tools.